NCT03500913View on ClinicalTrials.gov

Adipose Tissue and Serum Inflammation in GH Deficiency

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

May 19, 2019

Primary Completion Date

February 12, 2020

Study Completion Date

February 20, 2020

Conditions
Growth Hormone Deficiency
Interventions
DRUG

Growth Hormone

Patients will receive growth hormone replacement therapy as per standard clinical care during this study.

Trial Locations (1)

10032

Neuroendocrine Unit and Pituitary Center, Columbia University Irving Medical Center, New York

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Columbia University

OTHER

NCT03500913 - Adipose Tissue and Serum Inflammation in GH Deficiency | Biotech Hunter | Biotech Hunter